TARO News and Press, Taro Pharmaceutical Industries Ltd. From 08/09/18

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2018. Quarter ended June 30, 2018 Highlights - compared to June 30, 2017 Net sales of $154.6 million, de...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on Thursday, August 9, 2018. The release will be accessible on Taro’s website at www.taro.com . Abou...